Scopio Labs lands multi-million deal with Siemens for digital cell morphology tech
Scopio Labs lands multi-million deal with Siemens for digital cell morphology tech
The Israeli startup’s full-field digital cell morphology technology enables clinical laboratorians to examine patient blood cell samples digitally instead of under a microscope
Israeli startup Scopio Labs has signed strategic cooperation deals with two of the world’s leading medical equipment providers, Siemens Healthineers and Beckman Coulter. The expected revenue from the deals was not disclosed, but according to estimations is expected to reach tens of millions of dollars in the coming years.
Scopio Labs' full-field digital cell morphology technology enables clinical laboratorians to examine patient blood cell samples digitally instead of under a microscope, offering labs high-resolution, full-field viewing for peripheral blood specimens and artificial intelligence-based morphological analysis with remote capabilities through the secure hospital network.
The Scopio digital cell morphology platforms are intended for use in the central laboratory adjacent to hematology analyzers to examine patient blood cell samples digitally and remotely, instead of on a slide under a microscope. A patient sample is run on a hematology analyzer. When abnormalities in a patient blood sample are detected or further analysis is required, a blood smear is prepared, and the slide is transferred to the Scopio imaging platform for digitalization.
